Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02060188
Title A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon Cancer (CheckMate 142)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

Therapies

Nivolumab

Ipilimumab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | CAN | BEL

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Pacific Hematology Oncology Associates San Francisco California 94115 United States Details
Emory University Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute. Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Allina Health System Minneapolis Minnesota 55407 United States Details
Duke University Office of Research Administration Durham North Carolina 27710 United States Details
Novant Health Oncology Specialists Winston-Salem North Carolina 27103 United States Details
Providence Cancer Center Oncology and Hematology Care- Eastside Portland Oregon 97225 United States Details
Lehigh Valley Hospital Allentown Pennsylvania 18103 United States Details
University Of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University Med Ctr Nashville Tennessee 37232 United States Details
The University Of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Tasman Oncology Research Pty Ltd Southport Queensland 4215 Australia Details
The Royal Melbourne Hospital Parkville Victoria 3050 Australia Details
Local Institution Brussels 1000 Belgium Details
Local Institution Brussels 1090 Belgium Details
Local Institution Leuven 3000 Belgium Details
Local Institution Edmonton Alberta T6G 1Z2 Canada Details
Local Institution Toronto Ontario M5G 1X5 Canada Details
Local Institution Paris 75012 France Details
Local Institution Dublin 4 Ireland Details
Local Institution Dublin 9 Ireland Details
Local Institution Galway Ireland Details
Local Institution Candiolo TO 10060 Italy Details
Local Institution Modena 41124 Italy Details
Local Institution Padova Padova Italy Details
Local Institution Madrid 28009 Spain Details
Local Institution Madrid 28050 Spain Details
Local Institution Sevilla 41013 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field